{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:12:40Z","timestamp":1759590760471,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clineuro.2020.105886","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T20:32:04Z","timestamp":1588624324000},"page":"105886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Unusual adverse dermatologic conditions associated with fingolimod and natalizumab in a patient with relapsing remitting multiple sclerosis"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-1079","authenticated-orcid":false,"given":"Loulwah","family":"Mukharesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-7187","authenticated-orcid":false,"given":"Heidi","family":"Maloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Maiberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5566","key":"10.1016\/j.clineuro.2020.105886_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.clineuro.2020.105886_bib0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000492891","article-title":"Does natalizumab induce or aggravate psoriasis? A case study and review of the literature","volume":"10","author":"Lambrianides","year":"2018","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.clineuro.2020.105886_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.11.008","article-title":"The sphingosine-1-phosphate receptor: a novel therapeutic target for multiple sclerosis and other autoimmune diseases","volume":"175","author":"Mao-Draayer","year":"2017","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.clineuro.2020.105886_bib0020","article-title":"Pityriasis lichenoides-like drug reaction: a clinical histopathologic study of 10 cases","volume":"23","author":"Magro","year":"2017","journal-title":"Dermatol. Online J."},{"issue":"2","key":"10.1016\/j.clineuro.2020.105886_bib0025","first-page":"1128","article-title":"Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: a case report and review of the literature","volume":"17","author":"Fekete","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.clineuro.2020.105886_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2017.10.009","article-title":"Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis","volume":"187","author":"Miyazaki","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clineuro.2020.105886_bib0035","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40120-019-00162-7","article-title":"Fingolimod immune effects beyond its sequestration ability","volume":"8","author":"Sica","year":"2019","journal-title":"Neurol. Ther."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720302298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:33:48Z","timestamp":1759588428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720302298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":7,"alternative-id":["S0303846720302298"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105886","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual adverse dermatologic conditions associated with fingolimod and natalizumab in a patient with relapsing remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105886"}}